Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell




NEJM Resident 360 - Curbside Consults Podcast show

Summary: The number of medications available to treat diabetes continues to increase. Recently, there has been widespread interest in two classes of medications, the SGLT2 inhibitors and the GLP1 agonists. They have created quite the splash with improvements in cardiovascular outcomes in patients with type 2 diabetes. In this podcast...